Form D · Biotechnology
SunnyBay BioTech, Inc.
Fremont, CA · CIK 0001963621
Offering snapshot reported Jan 27, 2023 · SEC filing
- Reported sold
- $2.23M Offering amount: $5.98M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 27, 2023 | Initial | $2,230,915 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-471950
The amount sold includes $980,915.34 in converted notes.
Source: Form D, filed Jan 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Colabuono | Director |
| Xiangmin Cui | Director |
| Gary Johanning | Executive |
| Feng Wang Johanning | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
46283 Warm Springs Blvd.
Fremont, CA, 94539
Fremont, CA, 94539